Home > Financial Ratios > GLAND PHARMA
AD     Remove this Ad

GLAND PHARMA Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 0.950.640.600.400.40

What is the latest Fixed Capital/Sales ratio of GLAND PHARMA ?

The latest Fixed Capital/Sales ratio of GLAND PHARMA is 0.95 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20250.95
Mar20240.64
Mar20230.60
Mar20220.40
Mar20210.40

How is Fixed Capital/Sales of GLAND PHARMA Trending?

Years Fixed Capital/Sales % Change
Mar2025 0.95
48.44
Mar2024 0.64
6.67
Mar2023 0.6
50.00
Mar2022 0.4
0.00
Mar2021 0.4 -

Other Financial Ratios of GLAND PHARMA


Compare Fixed Capital/Sales ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹30,415.5 Cr 9.7% 10.8% 15.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹382,694.0 Cr -2.3% -7.3% -12.8% Stock Analytics
DIVIS LABORATORIES ₹160,721.0 Cr 0.8% -5.8% 4.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹134,016.0 Cr 0.8% 3.7% 20.8% Stock Analytics
CIPLA ₹106,946.0 Cr 0.7% -11.2% -6.5% Stock Analytics
DR REDDYS LABORATORIES ₹101,691.0 Cr -1.4% -3.8% -1.3% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

9.7%

10.8%

15.6%

SENSEX

-0.1%

-2.9%

7.5%


You may also like the below Video Courses